Fate Therapeutics

FATE

Capitalización de mercado USD 247 M

#	Nombre	Posición	Valor operado	Cambio en acciones	Cambio en la participación
1	1 Fidelity Investments Boston, Massachusetts	USD 7.32 M	–	–	–
2	2 Polaris Venture Management Co V Boston, Massachusetts	USD 4.2 M	–	–	–
3	KCM 3 Kingdon Capital Management New York	USD 3.84 M	–	–	–
4	4 Redmile Group San Francisco, California	USD 2.55 M	+USD 27.6 k	+15,200	+1%
5	5 Vanguard Group Malvern, Pennsylvania	USD 1.12 M	+USD 40.1 k	+22,098	+3%
6	6 Franklin Resources San Mateo, California	USD 850 k	–	–	–
7	BGA 7 Belmont Global Advisors Dallas, Texas	USD 680 k	-USD 149 k	-82,000	-17%
8	8 Bridgeway Capital Management Houston, Texas	USD 671 k	-USD 145 k	-80,000	-17%
9	9 Board of Trustees of The Leland Stanford Junior University Redwood City, California	USD 495 k	+USD 9.27 k	+5,114	+2%
10	10 Lombard Odier Asset Management (USA) New York	USD 436 k	+USD 12.8 k	+7,052	+3%
11	11 Renaissance Technologies New York	USD 307 k	-USD 76.1 k	-42,000	-19%
12	12 Jacobs Levy Equity Management Florham Park, New Jersey	USD 304 k	-USD 46.8 k	-25,800	-13%
13	13 Geode Capital Management Boston, Massachusetts	USD 183 k	–	–	–
14	TI 14 Telemetry Investments New York	USD 144 k	-USD 20.8 k	-11,500	-12%
15	15 Emerald Acquisition Seattle, Washington	USD 137 k	+USD 146 k	+80,604	Nuevas
16	16 BlackRock Fund Advisors San Francisco, California	USD 128 k	+USD 28.5 k	+15,701	+26%
17	17 Bank of New York Mellon New York	USD 117 k	+USD 8.96 k	+4,941	+8%
18	18 Goldman Sachs New York	USD 61 k	-USD 250 k	-137,958	-79%
19	19 Bank of America Charlotte, North Carolina	USD 48 k	+USD 167	+92	+0.3%
20	20 Northern Trust Chicago, Illinois	USD 43 k	–	–	–
21	21 Nationwide Fund Advisors Columbus, Ohio	USD 38 k	–	–	–
22	22 Tocqueville Asset Management New York	USD 37 k	–	–	–
23	TC 23 TFS Capital West Chester, Pennsylvania	USD 36 k	+USD 37.9 k	+20,925	Nuevas
24	24 Allianz Asset Management Munich, Germany	USD 31 k	-USD 325 k	-179,077	-91%
25	25 Deutsche Bank Frankfurt Am Main Ge, Germany	USD 30 k	-USD 46.5 k	-25,663	-59%

Fate Therapeutics FATE Capitalización de mercado USD 247 M

Fate Therapeutics

FATE

Capitalización de mercado USD 247 M